doi:10.1016/j.thromres.2020.03.003 59
Nausea is a common side effect, reported in a significant proportion of users in the COR clinical trial programme, and is thought to relate primarily to the bupropion component
Potential applications for anti-aging, include stimulating autophagy, reducing inflammation, and supporting improved wound healing and tissue repair
Weeks 1720+ Maintenance Dose (Wegovy 2.4 mg) Wegovy reaches its maintenance dose of 2.4 mg around week 17
You can then make an informed decision for yourself
Whats the Buzz The Bee Healthy Blog Direct-to-Employer GLP-1 Access: What Employers Need to Know Direct-to-employer GLP-1 access allows employers to bypass traditional PBMs, improving pricing transparency, cost predictability, and employee access to evidence-based obesity and chronic disease treatments